Reason for withdrawal from publication
This review is out of date, although it is correct at the date of publication. The review may be misleading as new studies could alter the original conclusions. All previous versions of the review can be found in the ‘Other versions’ tab. A new author team intends to develop four new reviews on this topic, which will serve to update and supersede this review. The new reviews will cover paracetamol, paracetamol plus opioids, NSAIDs, and NSAIDs plus opioids, for cancer pain. For more information, contact the PaPaS Review Group.
The editorial group responsible for this previously published document have withdrawn it from publication.
What's new
| Date | Event | Description |
|---|---|---|
| 31 July 2015 | Amended | This review has been withdrawn. See Published notes. |
History
Protocol first published: Issue 1, 2005 Review first published: Issue 1, 2005
| Date | Event | Description |
|---|---|---|
| 11 May 2011 | Amended | Contact details updated. |
| 6 November 2008 | Amended | Further minor RevMan 5 revisions for the conversion. |
| 9 April 2008 | Amended | Converted to new review format. |
Sources of support
Internal sources
Richard Saltonstall Charitable Foundation, USA.
The Evenor Armington Fund, USA.
External sources
Agency for Healthcare Research and Quality, Contract No:290‐97‐0019, USA.
Withdrawn from publication for reasons stated in the review